An international effort has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a rare and deadly cholesterol disorder, homozygous familial hypercholesterolemia.

Source: New medication shows promise as lipid-lowering therapy for rare cholesterol disorder


David Cottle

UBB Owner & Administrator